Double liver trouble: does having both hepatitis b and fatty liver speed up disease?

NCT ID NCT02863757

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study follows 1500 Chinese adults with chronic hepatitis B, nonalcoholic fatty liver disease, or both, to see how having both conditions changes the risk of serious liver problems like cirrhosis, liver failure, and liver cancer. Researchers will track who develops these complications and when. The goal is to understand whether the combination of the two liver diseases leads to faster or more severe disease progression than having either one alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If this study clarifies how having both hepatitis B and fatty liver disease affects liver health, it could guide better monitoring and treatment strategies for these patients.
What could go wrong
This is an observational study, not a treatment trial, so it will not test any new therapy. The results may show associations but cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Humanity and Health GI and Liver Centre

    RECRUITING

    Hong Kong, Hong Kong, 00852, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.